Shareholders need to know !The Job Guy, Herbert and Eric took-on?
Was it? to Deliver A Syringe that the Syringe/Medical Device Industry Would Buy, at a price that Maximized return for us? Do It Quickly As Possible to preserve maximum patent life, minimize share delution and capitalize on market opportunities, like 3 years of COVID?
The Job Performance of Guy, Herbert, Eric. Pass or Fail? What's your scorecard say?
Guy, Herbert, Eric. Are they telling us what came from their sales talks with BD and the rest of the syringe/medical device industry for buying the syringe, their sale talks after FDA gave it's safety approval?
What price did they tell the syringe industry competitors LOM wanted for the syringe?
What response did they get from each company?
Did they get any offer? Did BD, or any of them, tell them how much it would pay?
Herbert: chairman 10 1/2 years, Guy: president 5 1/2 years, Eric: director 6 years.?
Have Guy, Eric and Herbert been able to put the plastic parts together to make a syringe that satisfies industry/market standards and expectations? The elephant-in-the-room question.
Way different question than ' does it have FDA approval.' Is a clue to the answer found in the fact there is ' no sale '?
For years Guy and Herbert told us the syringe needed FDA approval so they could sell it. FDA approved the suringe as safe in Febr.
So Eric, Guy, Herbert, TELL US WHY, with FDA, no company is buying the syringe? TELL US: WHAT does your syringe not deliver that the industry and markets require?
At the Sept 4 video sideshow did Guy basically say or imply the syringe has little value?
Since they aren't telling us what happened with their sales talks and the reasons they can't get an offer, or if they got an offer why they aren't telling us what it was, does their silence suggest that after all the years to get FDA approval, that syringe industry/markets won't pay for whatever Guy, Herbert and Eric have been able to come up with or that the only offer they got is for a sum far les than expectations?
Is that WHY, after all the years they tried to get the syringe to work right, millions of dollars for multiple design changes, FDA costs, saleries etc., 17 million more share delution, half the core patent life gone, Guy now says the syringe has little value?
Fellow shareholders, were sale talks with BD and its competitors LOM's end-game? Where do Guy, Eric, Herbert go with the syringe if they've failed to find a buyer? Start over? Is that what they are telling us they are doing? Is it long past time for a NEW TEAM, one that can get the job done?
STILL
NUTTENTOSELL